Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Papillary thyroid cancer (PTC) is the most common thyroid malignancy.
• The tissue inhibitor of metalloproteinase-3 (TIMP3) gene functions as a tumor suppressor and is often downregulated in PTC due to promoter methylation.
• Previous studies demonstrated TIMP3's oncosuppressor role in PTC, affecting cell migration, invasion, and in vivo tumor progression.

Purpose of the Study:

• To elucidate the mediators of TIMP3's oncosuppressor activity in thyroid tumors.
• To investigate the TIMP3-related transcriptome in PTC.
• To understand the correlation between TIMP3 expression and the tumor microenvironment.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) database to analyze gene expression in PTC samples with varying TIMP3 levels.
• Performed genome-wide expression analysis on TIMP3-overexpressing and control cell lines (NIM1-T23 vs. NIM1-EV).
• Employed clusterProfiler for gene set and functional enrichment analysis, and CIBERSORT for immune cell distribution analysis.

Main Results:

• PTC tumors with high TIMP3 expression exhibited downregulated inflammation-related gene sets and a reduced protumoral hematopoietic cell fraction.
• TIMP3 overexpression in vitro led to downregulation of immune-related functions and enriched cell adhesion pathways.
• Functional enrichment analysis revealed modulation of cell adhesion, extracellular matrix organization, and vascular processes, consistent with previous findings.

Conclusions:

• TIMP3 expression levels are significantly correlated with the regulation of inflammatory functions in PTC.
• TIMP3 influences the immune infiltration composition, impacting PTC prognosis.
• These findings provide a comprehensive understanding of TIMP3's oncosuppressor role in papillary thyroid cancer.